IGFN1 Antibodies

Santa Cruz Biotechnology features a diverse variety of IGFN1 monoclonal antibodies for research applications. IGFN1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IGFN1, or Immunoglobulin-like and Fibronectin type III domain-containing protein 1, plays a crucial role in muscle development and regeneration. IGFN1 is involved in the organization of the extracellular matrix and is essential for maintaining muscle fiber integrity. Understanding IGFN1 function is vital for elucidating mechanisms underlying muscle-related diseases and conditions. Research into IGFN1 has revealed significant insights into muscle development pathways and potential therapeutic targets. Ongoing studies continue to uncover new aspects of IGFN1's role in muscle biology and disease progression. IGFN1 expression patterns have been documented across various muscle tissues, providing valuable information about its biological significance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of muscle development and related pathologies through precise and reliable detection of IGFN1.